Lymphoma, Large B-Cell, Diffuse Concept

subject area of

• A rare cause of complete heart block in an adult: Primary cardiac lymphoma  Journal Articles
• Aspiration biopsy cytology of lymph nodes in malignant lymphoma  Journal Articles
• Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection  Journal Articles
• Breast implant-associated EBV-positive diffuse large B-cell lymphoma: Two case reports and literature review  Journal Articles
• Critical assessment of automated flow cytometry data analysis techniques  Journal Articles
• Evaluation of Subcutaneous Rituximab Administration on Canadian Systemic Therapy Suites  Journal Articles
• Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy  Journal Articles
• Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma  Journal Articles
• Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice  Journal Articles
• Glia-specific antigen in the intracranial tumors. Immunofluorescence study  Journal Articles
• Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness  Journal Articles
• Implications of using a prognostic index to select therapy for patients with aggressive histology lymphoma.  Journal Articles
• Inappropriate antidiuretic hormone complicating histiocytic lymphoma  Journal Articles
• Intravascular Large B-Cell Lymphoma of the Uterus: A Diagnostic Challenge  Journal Articles
• Invasive Crooke cell adenoma in a patient with diffuse large B-cell lymphoma  Journal Articles
• Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study  Journal Articles
• Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma  Journal Articles
• Lymphoma with hypercalcemia.  Journal Articles
• Morphometric analysis of bovine lymphomas classified according to the National Cancer Institute working formulation  Journal Articles
• Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013  Journal Articles
• Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital  Journal Articles
• Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting  Journal Articles
• Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma  Journal Articles
• Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With CHOP Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda.  Journal Articles
• Primary ???Cutaneous??? T-Cell Anaplastic Large Cell Lymphoma, CD30+, Neutrophil-Rich Variant with Subcutaneous Panniculitic Lesions, in a Post-Renal Transplant Patient  Journal Articles
• R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial  Journal Articles
• Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry.  Journal Articles
• Recurrent genomic rearrangements in primary testicular lymphoma.  Journal Articles
• Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12  Journal Articles
• Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study  Journal Articles
• Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation  Journal Articles
• The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada  Journal Articles
• The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL  Journal Articles
• Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL  Journal Articles
• Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma  Journal Articles
• Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma  Journal Articles
• Tumours of the mononuclear phagocyte system: A review of clinical and pathological features  Journal Articles